Management of Urinary incontinence in Post Hysterectomy and Post Menopausal Women with Unani drug.

A Clinical Trial Of Majoon E Kundur in Management of Urinary Incontinence in post Hysterectomy and post Menopausal Women (Silsul Boul Baad inkhate Rahem aur Baad San-E-Yass ka Ilaj Bazariye Majun E Kundur).

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/08/044851

Enrollment

Registered

2022-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N329- Bladder disorder, unspecified

Interventions

Intervention1: Majoon E kundur: Majoon E kundur Drug of choice for urinary incontinence. COMPOSITION: Mastagi-100 grms Kundur-100grms Baloot-100grms Gulnarfarsi-100grms Kalongi-100grms Kishneez kushk-

Eligibility

Inclusion criteria

Inclusion criteria: Female patients of age less than 60yrs. Postmenopausal women. Patients with post hysterectomy urinary incontinence. Clinically stable patients.

Exclusion criteria

Exclusion criteria: Women with Urinary tract infection. Diabetic patients. Women with renal disorders. Patients on diuretics. Patients with 2nd,3rd, and 4th-degree uterine prolapse. Urogenital malignancy. Patients with deranged kidney, hepatic and cardiac profile

Design outcomes

Primary

Measure	Time frame
Any effect like cure, relieved or uneffectedTimepoint: 3 months	—

Secondary

Measure	Time frame
Any effect on quality of lifeTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Shahzadi Sultana

Govt.Nizamia Tibbi College and Hospital

drssntc@gmail.com9908624090

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026